Can MRSA Surveillance Results Be Used to Discontinue Vancomycin for Infections Other Than Pneumonia?
At the IDWeek 2023, Dr. Rebekah W. Moehring from the Duke Center for Antimicrobial Stewardship and Infection Control at Duke University presented a fascinating report on the use of MRSA surveillance in guiding empirical therapy for MRSA and de-escalation strategies to optimize vancomycin antibiotic management.